NEULAND LABORATORIES LTD. - 524558 - Corporate Action-Board approves Dividend
Board approved Dividend for FY 2018-1916-05-2019
16-05-2019
Neuland Laboratories Ltd - 524558 - Outcome of Board Meeting
Outcome of Board Meeting held on May 16, 201916-05-2019
Neuland Laboratories Ltd - 524558 - Audited Financial Results For Quarter And Financial Year Ended March 31, 2019
Audited Financial Results for quarter and Financial year ended March 31, 201916-05-2019
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Earnings Call Notice13-05-2019
Neuland Laboratories Ltd - 524558 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 201808-05-2019
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Newspaper Publication dated May 4, 201904-05-2019
Neuland Laboratories Ltd - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 201503-05-2019
NEULAND LABORATORIES LTD. - 524558 - Corporate Action-Board to consider Dividend
Company Update02-05-2019
NEULAND LABORATORIES LTD. - 524558 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayNEULAND LABORATORIES LTD. 2CININE794A01010 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 824060000 4Highest Credit Rating during the previous FY BBB+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sarada Bhamidipati Designation: Company Secretary EmailId: saradab@neulandlabs.com Name of the Chief Financial Officer: Amit Agarwal Designation: Chief Financial Officer EmailId: amitagarwal@neulandlabs.com Date: 30/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.30-04-2019